SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 78.09 |
Enterprise Value ($M) | -7.67 |
Book Value ($M) | 128.86 |
Book Value / Share | 2.90 |
Price / Book | 0.61 |
NCAV ($M) | 128.86 |
NCAV / Share | 2.90 |
Price / NCAV | 0.61 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.21 |
Return on Assets (ROA) | -0.19 |
Return on Equity (ROE) | -0.19 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 37.11 |
Current Ratio | 37.11 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 132.67 |
Assets | 132.67 |
Liabilities | 3.81 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Rtw Investments, Lp | 7.40 | 41.89 | |
13G/A | Bb Biotech Ag | 0.00 | -100.00 | |
13G/A | PFM Health Sciences, LP | 6.20 | ||
13D | Tang Capital Management Llc | 9.70 | ||
13G | BML Investment Partners, L.P. | 9.40 | ||
13G | Morgan Stanley | 9.50 | ||
13G/A | Soleus Capital, LLC | 9.80 | 11.84 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
135,656 | 348,075 | 38.97 | |
25,132 | 259,311 | 9.69 | |
43,024 | 182,374 | 23.59 | |
58,832 | 229,370 | 25.65 | |
(click for more detail) |
Similar Companies | |
---|---|
ENTO – Entero Therapeutics, Inc. | ENTX – Entera Bio Ltd. |
ENVB – Enveric Biosciences, Inc. | EQ – Equillium, Inc. |
ERNA – Eterna Therapeutics Inc. |
Financial data and stock pages provided by
Fintel.io